Ellie is a partner in Polaris’s Boston Office and also manages the Polaris Innovation Fund. She was the founding president of Volastra Therapeutics. She also serves on the boards of Muna Therapeutics, Montis Biosciences, Candesant Biomedical, and Satellite Biosciences and is an expert in residence for the Harvard Office of Technology Development. Prior to co-founding the Polaris Innovation Fund, Ellie was the head of business development at Lyndra. She previously held leadership and consulting positions in business development, operations, and strategy in multiple life science companies including Arsia Therapeutics, Lyndra, and XTuit Pharmaceuticals.